Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.

The International Chamber of Commerce (ICC), the world business organization representing more than 4.5-million-member ...

SmallCap stocks can often be overlooked by institutional investors, yet they offer outsized return potential for those ...

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

I find that sustained success now demands a new kind of leadership grounded in agility, strategic foresight and courage.

Google will spend $85 billion on artificial-intelligence projects this year. Its rivals are likely to spend more.

AI is dumbing us down. But paradoxically, when used judiciously in combination with human thought, the very same tool could ...

The EC has approved Janssen-Cilag International’s new indication for Darzalex Faspro (daratumumab) to treat adults with SMM.

While FDA Commissioner Marty Makary emphasizes learning and humility, the FDA has systematically removed the very experience ...

I didn’t leave medicine behind when I stepped out of the operating room. I carried its lessons with me into leadership. Today, I see myself as a leader who also happens to be a physician, and that ...